共 50 条
- [1] Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma [J]. BLOOD CANCER JOURNAL, 2018, 8
- [2] Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma [J]. Blood Cancer Journal, 8
- [3] Bortezomib and dexamethasone administration in multiple myeloma after autologous stem cell transplantation [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 148 - 148
- [4] RETROSPECTIVE COMPARISON OF BORTEZOMIB WITH VINCRISTINE-DOXORUBICIN-DEXAMETHASONE (VAD) AS INDUCTION TREATMENT PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 87 - 87
- [6] Complete response after autologous stem cell transplant in multiple myeloma [J]. CANCER MEDICINE, 2014, 3 (04): : 939 - 946
- [10] Patient-reported outcomes following autologous stem cell transplant for patients with multiple myeloma [J]. EJHAEM, 2021, 2 (03): : 488 - 492